{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:33:35Z","timestamp":1777433615139,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.ejphar.2007.03.043","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T07:12:44Z","timestamp":1175497964000},"page":"153-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model"],"prefix":"10.1016","volume":"566","author":[{"given":"Jun","family":"Iwanami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Juan","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Tsukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.03.043_bib1","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1161\/01.RES.0000102404.81461.25","article-title":"Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface","volume":"93","author":"Ahokas","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2007.03.043_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1096\/fasebj.14.5.779","article-title":"Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate","volume":"14","author":"Almeida","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2007.03.043_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1210\/endo-98-3-676","article-title":"Corticoid receptors in rat brain: evidence for an aldosterone receptor","volume":"98","author":"Anderson","year":"1976","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2007.03.043_bib4","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejphar.2007.03.043_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004647-200101000-00002","article-title":"Reactive oxygen radicals in signaling and damage in the ischemic brain","volume":"21","author":"Chan","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2007.03.043_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI118392","article-title":"Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke","volume":"97","author":"Connolly","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2007.03.043_bib7","doi-asserted-by":"crossref","first-page":"R944","DOI":"10.1152\/ajpregu.2001.281.3.R944","article-title":"Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats","volume":"281","author":"Dorrance","year":"2001","journal-title":"Am. J. Physiol., Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2007.03.043_bib8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.HYP.0000196945.73586.0d","article-title":"Mineralocorticoid receptor activation causes cerebral vessel remodeling and exacerbates the damage caused by cerebral ischemia","volume":"47","author":"Dorrance","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2007.03.043_bib9","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1161\/01.STR.0000021902.33129.69","article-title":"Inflammatory cell adhesion molecules in ischemic cerebrovascular disease","volume":"33","author":"Frijns","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2007.03.043_bib10","first-page":"E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.03.043_bib11","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1126\/science.7522345","article-title":"Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase","volume":"265","author":"Huang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2007.03.043_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.CIR.0000138848.58269.80","article-title":"Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation","volume":"110","author":"Iwai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2007.03.043_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10741-005-2346-0","article-title":"Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation","volume":"10","author":"Joffe","year":"2005","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2007.03.043_bib14","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2007.03.043_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","article-title":"Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients","volume":"40","author":"Krum","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2007.03.043_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0006-8993(02)03685-5","article-title":"Changes in oxidative stress, iNOS activity and neutrophil infiltration in severe transient focal cerebral ischemia in rats","volume":"958","author":"Lerouet","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.03.043_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-128X(01)00176-3","article-title":"Nongenomic effects of aldosterone: cellular aspects and clinical implications","volume":"67","author":"Losel","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.ejphar.2007.03.043_bib18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/01.STR.28.9.1821","article-title":"The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats","volume":"28","author":"MacLeod","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2007.03.043_bib19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00004647-199910000-00005","article-title":"Larger anastomoses in angiotensinogen-knockout mice attenuate early metabolic disturbances after middle cerebral artery occlusion","volume":"19","author":"Maeda","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2007.03.043_bib20","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","article-title":"Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells","volume":"109","author":"Mazak","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2007.03.043_bib21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/en.2004-1130","article-title":"Eplerenone blocks nongenomic effects of aldosterone on the Na+\/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels","volume":"146","author":"Michea","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2007.03.043_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000180753.63183.95","article-title":"Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells","volume":"97","author":"Min","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2007.03.043_bib23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.amjhyper.2006.04.009","article-title":"Amlodipine treatment reduces stroke size in apolipoprotein e-deficient mice","volume":"19","author":"Mogi","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2007.03.043_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","article-title":"Cardiovascular complications in patients with primary aldosteronism","volume":"33","author":"Nishimura","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejphar.2007.03.043_bib25","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.ejphar.2007.03.043_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2007.03.043_bib27","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2007.03.043_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2007.03.043_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure","volume":"93","author":"Qin","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2007.03.043_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tem.2005.09.002","article-title":"Aldosterone: good guy or bad guy in cerebrovascular disease?","volume":"16","author":"Rigsby","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2007.03.043_bib31","unstructured":"Rigsby, C.S., Pollock, D.M., Dorrance, A.M., in press. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats. Microvasc. Res."},{"key":"10.1016\/j.ejphar.2007.03.043_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2007.03.043_bib33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2007.03.043_bib34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.ATV.0000204635.75748.0f","article-title":"Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation","volume":"26","author":"Suzuki","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2007.03.043_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/hq0102.102189","article-title":"Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury","volume":"22","author":"Szocs","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2007.03.043_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1291\/hypres.22.147","article-title":"Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics","volume":"22","author":"Timmermans","year":"1999","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2007.03.043_bib37","first-page":"F319","article-title":"Early aldosterone action: toward filling the gap between transcription and transport","volume":"277","author":"Verrey","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.03.043_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2007.03.043_bib39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/01.HYP.0000140771.21243.ed","article-title":"Mechanism for aldosterone potentiation of angiotensin II-stimulated rat arterial smooth muscle cell proliferation","volume":"44","author":"Xiao","year":"2004","journal-title":"Hypertension"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907003950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907003950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T03:58:49Z","timestamp":1762142329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907003950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":39,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0014299907003950"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.03.043","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.03.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}